Change of Company Secretary and Registered Office
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your HEMO notes
Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical company developing innovative therapies for blood malignancies, announces that Ben Harber has resigned as Company Secretary of the Company with effect from 31 December 2024.
The Company is pleased to announce the appointment of Westend Corporate LLP as Corporate Company Secretary, effective 1 January 2025.
It also announces that it has changed its registered office to 6 Heddon Street, London, W1B 4BT from 1 January 2025.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.